Medical Care

Global Cell and Gene Therapy Manufacturing Quality Control Market Research Report 2025

The global market for Cell and Gene Therapy Manufacturing Quality Control was valued at US$ 557 million in the year 2024 and is projected to reach a revised size of US$ 1854 million by 2031, growing at a CAGR of 19.0% during the forecast period.
North American market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell and Gene Therapy Manufacturing Quality Control in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell and Gene Therapy Manufacturing Quality Control include Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Intertek Group Plc, Eurofins Scientific S.E., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing Quality Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing Quality Control.
The Cell and Gene Therapy Manufacturing Quality Control market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Manufacturing Quality Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Manufacturing Quality Control companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad Laboratories,Inc.
QIAGEN
Charles River Laboratories International, Inc.
Lonza Group AG
Bio-Techne Corporation
Merck KGaA
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific, Inc.
Intertek Group Plc
Eurofins Scientific S.E.
Segment by Type
Sterility Testing
Purity Testing
Potency Testing
Identity Testing
Others
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Manufacturing Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing Quality Control company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sterility Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Manufacturing Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Manufacturing Quality Control Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Manufacturing Quality Control Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Quality Control Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Quality Control Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Quality Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Manufacturing Quality Control Revenue
3.4 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories,Inc.
11.1.1 Bio-Rad Laboratories,Inc. Company Details
11.1.2 Bio-Rad Laboratories,Inc. Business Overview
11.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.1.4 Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.1.5 Bio-Rad Laboratories,Inc. Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Introduction
11.2.4 QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.2.5 QIAGEN Recent Development
11.3 Charles River Laboratories International, Inc.
11.3.1 Charles River Laboratories International, Inc. Company Details
11.3.2 Charles River Laboratories International, Inc. Business Overview
11.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.3.4 Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.3.5 Charles River Laboratories International, Inc. Recent Development
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Details
11.4.2 Lonza Group AG Business Overview
11.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Introduction
11.4.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.4.5 Lonza Group AG Recent Development
11.5 Bio-Techne Corporation
11.5.1 Bio-Techne Corporation Company Details
11.5.2 Bio-Techne Corporation Business Overview
11.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Introduction
11.5.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.5.5 Bio-Techne Corporation Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Introduction
11.6.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.6.5 Merck KGaA Recent Development
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Ltd Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 Intertek Group Plc
11.9.1 Intertek Group Plc Company Details
11.9.2 Intertek Group Plc Business Overview
11.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Introduction
11.9.4 Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.9.5 Intertek Group Plc Recent Development
11.10 Eurofins Scientific S.E.
11.10.1 Eurofins Scientific S.E. Company Details
11.10.2 Eurofins Scientific S.E. Business Overview
11.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.10.4 Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
11.10.5 Eurofins Scientific S.E. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sterility Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Others
Table 7. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2020-2025)
Table 11. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2026-2031)
Table 13. Cell and Gene Therapy Manufacturing Quality Control Market Trends
Table 14. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Table 15. Cell and Gene Therapy Manufacturing Quality Control Market Challenges
Table 16. Cell and Gene Therapy Manufacturing Quality Control Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Players (2020-2025)
Table 19. Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2024)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing Quality Control Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Headquarters and Area Served
Table 23. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
Table 24. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Type (2020-2025)
Table 28. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Type (2026-2031)
Table 30. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Application (2020-2025)
Table 32. Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Application (2026-2031)
Table 34. North America Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bio-Rad Laboratories,Inc. Company Details
Table 50. Bio-Rad Laboratories,Inc. Business Overview
Table 51. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 52. Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 53. Bio-Rad Laboratories,Inc. Recent Development
Table 54. QIAGEN Company Details
Table 55. QIAGEN Business Overview
Table 56. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product
Table 57. QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 58. QIAGEN Recent Development
Table 59. Charles River Laboratories International, Inc. Company Details
Table 60. Charles River Laboratories International, Inc. Business Overview
Table 61. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 62. Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 63. Charles River Laboratories International, Inc. Recent Development
Table 64. Lonza Group AG Company Details
Table 65. Lonza Group AG Business Overview
Table 66. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product
Table 67. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 68. Lonza Group AG Recent Development
Table 69. Bio-Techne Corporation Company Details
Table 70. Bio-Techne Corporation Business Overview
Table 71. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product
Table 72. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 73. Bio-Techne Corporation Recent Development
Table 74. Merck KGaA Company Details
Table 75. Merck KGaA Business Overview
Table 76. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product
Table 77. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 78. Merck KGaA Recent Development
Table 79. F. Hoffmann-La Roche Ltd Company Details
Table 80. F. Hoffmann-La Roche Ltd Business Overview
Table 81. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product
Table 82. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 83. F. Hoffmann-La Roche Ltd Recent Development
Table 84. Thermo Fisher Scientific, Inc. Company Details
Table 85. Thermo Fisher Scientific, Inc. Business Overview
Table 86. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 87. Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 88. Thermo Fisher Scientific, Inc. Recent Development
Table 89. Intertek Group Plc Company Details
Table 90. Intertek Group Plc Business Overview
Table 91. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product
Table 92. Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 93. Intertek Group Plc Recent Development
Table 94. Eurofins Scientific S.E. Company Details
Table 95. Eurofins Scientific S.E. Business Overview
Table 96. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product
Table 97. Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025) & (US$ Million)
Table 98. Eurofins Scientific S.E. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report


List of Figures
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Picture
Figure 2. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Type: 2024 VS 2031
Figure 4. Sterility Testing Features
Figure 5. Purity Testing Features
Figure 6. Potency Testing Features
Figure 7. Identity Testing Features
Figure 8. Others Features
Figure 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application: 2024 VS 2031
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Contract Manufacturing Organizations Case Studies
Figure 13. Cell and Gene Therapy Manufacturing Quality Control Report Years Considered
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell and Gene Therapy Manufacturing Quality Control Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region: 2024 VS 2031
Figure 17. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Players in 2024
Figure 18. Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2024
Figure 20. North America Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2020-2031)
Figure 22. United States Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2020-2031)
Figure 26. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2020-2031)
Figure 34. China Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2020-2031)
Figure 42. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Share by Country (2020-2031)
Figure 46. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Bio-Rad Laboratories,Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 50. QIAGEN Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 51. Charles River Laboratories International, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 52. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 53. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 54. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 55. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 56. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 57. Intertek Group Plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 58. Eurofins Scientific S.E. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies